Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

DECEMBER 14, 2021

IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

NORML

DECEMBER 6, 2019

Authors concluded, “Further research is needed in this field, but CBD, as an alternative to THC, should be taken into consideration in the therapy of masticatory muscles in patients with TMD.” Subjects receiving treatment reported no adverse effects.

Clinical Trials 108

Clinical Trials Patients CBD Therapy 108

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Long before THC was discovered in the 1940s , CBN was first identified at the turn of the 20th century from a plant that was then known as Indian hemp. Converting THC to CBN happens through oxidation.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

The Joint Blog

NOVEMBER 8, 2020

For the study researchers examined the efficacy of high-THC marijuana oil versus a placebo in patients with fibromyalgia over an eight-week period. mg of THC and 0.08 It can be found below: Objective: To determine the benefit of a tetrahydrocannabinol (THC)-rich cannabis oil on symptoms and quality of life of fibromyalgia patients.

Clinical Trials 49

Clinical Trials Oil Therapy Marijuana 49

NORML

JULY 26, 2019

Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research. According to reporting by the Associated Press , marijuana crops will include plants of varying THC and CBD potencies, including strains high in cannabidiol.

Clinical Trials 195

Clinical Trials Marijuana Strains THC 195

Otherside Farms

JANUARY 24, 2019

Geoffrey Guy, chairman of the pharmaceutical company, told reporters that the purified drug contains no tetrahydrocannabinol (THC), the psychotropic ingredient in marijuana causing the recreational high. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Veriheal

JANUARY 11, 2023

Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. How do you feel about this being the largest cannabis impairment clinical trial ever?

Clinical Trials 98

Clinical Trials THC Data Safety 98

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Veriheal

MARCH 2, 2024

Yet, at the same time, the new amendment to Japan’s cannabis control legislation will also impose harsher bans and punishments for the consumption of recreational tetrahydrocannabinol (THC)-containing cannabis products. In Japan, THC-based products are designated as narcotics to be regulated.

Legalization 106

Legalization Epilepsy Clinical Trials THC 106

Leafly

OCTOBER 4, 2022

A drug that blocks the brain's cannabinoid receptors is now in clinical trials and showing promising results. The post Are you too high? A promising new ‘comedown drug’ may be on the way appeared first on Leafly.

Clinical Trials 104

Clinical Trials Cannabinoids Medicine THC 104

Cannabis Law Report

JANUARY 11, 2022

Ripple has incorporated a precise dose of cannabinol (CBN) and THC into the new line of products, allowing consumers to experience the benefits of an unadulterated cannabinoid product without any added sleep aids such as melatonin or valerian root, which can leave the consumer with an unwanted sedative feeling the next day.

THC 52

THC Clinical Trials Research and Development Sleep 52

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. The flower contained high levels of THC in the range of 15-25 milligrams, with CBD content resting on the lower end of the spectrum at 0.5

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

The Cannigma

OCTOBER 11, 2021

No clinical trial was used in the compilation of the study. The researchers themselves wrote that the study is the first “to document self-reported efficacy of CBG-predominant products,” and provides further indication that “CBG-predominant cannabis-based medicines should be studied in randomized controlled trials.”.

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

NORML

APRIL 15, 2019

.” A separate study published in 2017 reported that U-Miss samples contain far lower levels of both THC and CBD than do commercially available cannabis. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.

Hemp 197

Hemp Clinical Trials Marijuana Programs 197

Cannabis Law Report

JULY 4, 2021

The level of THC in CBD products should fall below 0.2% Also, alone it won’t create the “high” sensation associated with the use of Tetrahydrocannabinol or THC. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. What is THC? CBD vs THC.

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 104

Oil THC Cannabinoids Research and Development 104

Cannabis Law Report

MARCH 22, 2020

Mugglehead reports… Previous tests with THC in mice with influenza showed an increase in viral loads. A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. 9:46 AM – Mar 19, 2020.

THC 59

THC Clinical Trials Data Consumption 59

Weedistry

MARCH 7, 2019

But the cancer cells died each time they were exposed to tetrahydrocannabinol ( THC ), the principal psychoactive ingredient of marijuana. Instead of gaining insight into how cells function, Sanchez had stumbled upon the anti-cancer properties of THC. THC and cannabidiol both induce apoptosis in leukemic cell lines.

THC 40

THC CBD Clinical Trials Research and Development 40

TheAnswerPage

NOVEMBER 30, 2021

Psilocybin, the hallucinogen found in “magic mushrooms” has been used in clinical trials. THC is also a schedule I substance.) Schedule I substances cannot be used in clinical trials n the US (without special permission).

Clinical Trials 52

Clinical Trials Safety Treatment THC 52

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. But one of the most famous and most widely known phrases associated with the plant will always be THC, or more appropriately, delta-9-tetrahydrocannabinol. THC Basics: Perceptions in Today’s Society.

THC 66

THC Patients Blood Pressure Clinical Trials 66

Canna Care Docs

OCTOBER 3, 2023

Alleviating Symptoms with Cannabinoids As more states legalize medical cannabis, many researchers and clinicians are studying the efficacy of cannabinoids like THC and CBD for alleviating these symptoms. This study looked at major cannabinoids such as THC and their accuracy and effectiveness in treating the effects of nausea and vomiting.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Project CBD

MARCH 21, 2023

That’s what appeared to happen in rats injected with the synthetic CB1 agonists WIN55,212‐2 and CP55,940 in a 2010 study 4 and THC and CBD in a 1:1 ratio in a 2011 follow-up study. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

The Fresh Toast

JULY 22, 2020

Clinical trial results indicate cannabis could provide an alternative or adjunctive treatment to sickle cell patients. Marijuana Shows Promise In Sickle Cell Disease Treatment. The post Marijuana Shows Promise In Sickle Cell Disease Treatment appeared first on The Fresh Toast.

Treatment 105

Treatment Clinical Trials Marijuana Patients 105

FloridaMarijuana.net

AUGUST 16, 2018

The clinical trials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia. The Journal of Psychopharmacology analyzed a study in which THC was used to determine its effects on Dementia patients’ balance. 9-tetrahydrocannabinol (?9-THC)

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

MMJ Recs

APRIL 1, 2024

Unlike its counterpart THC (tetrahydrocannabinol), CBD doesn’t produce psychoactive effects, making it an attractive option for those seeking therapeutic relief without the “high” associated with traditional marijuana use.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

AUGUST 10, 2022

The lead investigators are Jacobo Mintzer , MD, MBA, Brigid Reynolds , ANP-BC, and the Alzheimer’s Clinical Trial Consortium (ACTC).The ” Study Details – provided by Alzheimer’s Clinical Trial Consortium. MediPharm Labs Corp. Logo (CNW Group/MediPharm Labs Corp.).

Clinical Trials 52

Clinical Trials Medicine Pharmaceutical THC 52

SpeedWeed

AUGUST 5, 2021

As a growing number of states step in to regulate these controversial substances, such as delta-8 tetrahydrocannabinol (THC), multiple cannabinoids join the fray. A semi-synthetic cannabinoid known as THC-O acetate is one substance gaining attention. Certainly THC-O acetate falls in that category. Why would someone do this?

THC 52

THC Vaping Cannabinoids Blood Pressure 52

The Cannigma

APRIL 12, 2023

The MoreBetter & CBDistillery CBN study CBN, or cannabinol , is a natural product of THC degradation; it can be found in aged, poorly stored cannabis plants and also in cannabis smoke. Like THC , CBN is a natural anti-inflammatory. Sleep is not often the focus of clinical trials on cannabis; rather it is often a secondary outcome.

Sleep 133

Sleep Data Tincture Research and Development 133

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. THC is the psychoactive compound responsible for the “high” associated with marijuana use.

Law 52

Law Dispensary Clinical Trials Programs 52

The Cannigma

JUNE 14, 2021

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit. A promise made years ago.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

The Joint Blog

APRIL 17, 2020

According to a new study in the Journal of Clinic Medicine , the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Cannabis Sativa, a.k.a

Events 48

Events THC Chronic Pain Sleep 48

The Cannigma

DECEMBER 14, 2021

This synthetic derivative of naturally occurring delta-9-Tetrahydrocannabinol (delta-9-THC) was first reported by noted cannabis chemist Professor Roger Adams at the University of Illinois in 1940. It was also later found that HHC can be produced in the lab during the conversion of THC to CBN in what is known as a disproportionation reaction.

Research and Development 116

Research and Development Cannabinoids Clinical Trials THC 116

TheAnswerPage

JANUARY 21, 2021

Over the past two decades, PRECLINICAL data indicate that THC, CBD, as well as some synthetic cannabinoids induce apoptosis of cancer cells and inhibit tumor proliferation, metastasis, and angiogenesis. Note: The results of preclinical trials are NOT equivalent to clinical trials. What have the results indicated?

Clinical Trials 52

Clinical Trials Data Cannabinoids THC 52

The Cannigma

MAY 13, 2022

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. When this system alone can’t manage the pain, outside cannabinoids like THC can help. THC has several properties that make it effective at treating pain: Reducing inflammation Reducing pain Preventing/reducing vomiting.

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111